Globally, Novartis is sponsoring four treatment-free remission studies and providing support for four investigator-initiated studies. More information on the Novartis-sponsored trials, including addresses and contact information for each study site, can be found at:
Stopping treatment is not a clinical recommendation and should only be attempted in the context of a well conducted clinical study. A very important part of these treatment-free remission studies is the inclusion of regular molecular monitoring with International Scale Real-Time Quantitative Polymerase Chain Reaction (IS RT-Q-PCR) testing. Once treatment is stopped molecular monitoring is used to identify if a patient's level of disease remains in deep molecular response or if the reintroduction of treatment is needed.
The foregoing release contains forward-looking statements that can be identified by terminology such as "to evaluate," "can," "potential," "continued," "dedication," "ongoing," "may," "con
Copyright©2012 PR Newswire.
All rights reserved